1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Nitric oxide and its possible implication in ME/CFS (Part 1 of 2)
Andrew Gladman explores the current and historic hypotheses relating to nitric oxide problems in ME/CFS. Part 1 of a 2-part series puts nitric oxide under the microscope and explores what it is, what it does and why it is so frequently discussed in the world of ME/CFS. Part 1 focuses...
Discuss the article on the Forums.

Rituximab for Hep C not responding to antivirals - relapse risk remains

Discussion in 'Other Health News and Research' started by natasa778, Jan 31, 2014.

  1. natasa778

    natasa778 Senior Member

    Messages:
    1,494
    Likes:
    1,369
    London UK
    Small scale trial but very encouraging and interesting results

    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.


     
    Bob likes this.
  2. natasa778

    natasa778 Senior Member

    Messages:
    1,494
    Likes:
    1,369
    London UK
    Should have mentioned FATIGUE being present in 2/3 of Hep C patients, amongst other clinical presentations. Would be interesting to know if that changes after Rituximab treatment ...

    Cryoglobulin production present in over a third.
     

See more popular forum discussions.

Share This Page